DUBLIN, June 15, 2023 /PRNewswire/ — The “Induced Pluripotent Stem Cell (iPSC) – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
Global Induced Pluripotent Stem Cell ((iPSC) Market to Reach $3.1 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Induced Pluripotent Stem Cell ((iPSC) estimated at US$1.8 Billion in the year 2022, is projected to reach a revised size of US$3.1 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2022-2030. Vascular Cells, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Cardiac Cells segment is readjusted to a revised 8.1% CAGR for the next 8-year period.
The U.S. Market is Estimated at $820.4 Million, While China is Forecast to Grow at 8.8% CAGR
The Induced Pluripotent Stem Cell ((iPSC) market in the U.S. is estimated at US$820.4 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$116.8 Million by the year 2030 trailing a CAGR of 8.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.
Select Competitors (Total 51 Featured)
- Lonza Group Ltd.
- Evotec SE
- FUJIFILM Holdings Corporation
- Abcam PLC
- Horizon Discovery Ltd.
- Cell Signaling Technology, Inc.
- Cell Applications, Inc.
- Invivogen
- ALSTEM, LLC
- Censo Biotechnologies Ltd.
- Creative Bioarray
- Creative Biolabs
- Axol Bioscience Ltd.
- ID Pharma Co., Ltd.
- BlueRock Therapeutics, LLC
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- Impact of Covid-19 and a Looming Global Recession
- Induced Pluripotent Stem Cells (iPSCs) Market Gains from Increasing Use in Research for COVID-19
- Studies Employing iPSCs in COVID-19 Research
- Stem Cells, Application Areas, and the Different Types: A Prelude
- Applications of Stem Cells
- Types of Stem Cells
- Induced Pluripotent Stem Cell (iPSC): An Introduction
- Production of iPSCs
- First & Second Generation Mouse iPSCs
- Human iPSCs
- Key Properties of iPSCs
- Transcription Factors Involved in Generation of iPSCs
- Noteworthy Research & Application Areas for iPSCs
- Induced Pluripotent Stem Cell ((iPSC) Market: Growth Prospects and Outlook
- Drug Development Application to Witness Considerable Growth
- Technical Breakthroughs, Advances & Clinical Trials to Spur Growth of iPSC Market
- North America Dominates Global iPSC Market
- Competition
- Recent Market Activity
- Select Innovation/Advancement
- Induced Pluripotent Stem Cell (iPSC) – Global Key Competitors Percentage Market Share in 2021 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2021 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Effective Research Programs Hold Key in Roll Out of Advanced iPSC Treatments
- Induced Pluripotent Stem Cells: A Giant Leap in the Therapeutic Applications
- Research Trends in Induced Pluripotent Stem Cell Space
- Worldwide Publication of hESC and hiPSC Research Papers for the Period 2008-2010, 2011-2013 and 2014-2016
- Number of Original Research Papers on hESC and iPSC Published Worldwide (2014-2016)
- Concerns Related to Embryonic Stem Cells Shift the Focus onto iPSCs
- Regenerative Medicine: A Promising Application of iPSCs
- Induced Pluripotent: A Potential Competitor to hESCs?
- Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
- Global Stem Cell & Regenerative Medicine Market by Product (in %) for the Year 2019
- Global Regenerative Medicines Market by Category: Breakdown (in %) for Biomaterials, Stem Cell Therapies and Tissue Engineering for 2019
- Pluripotent Stem Cells Hold Significance for Cardiovascular Regenerative Medicine
- Leading Causes of Mortality Worldwide: Number of Deaths in Millions & % Share of Deaths by Cause for 2017
- Leading Causes of Mortality for Low-Income and High-Income Countries
- Growing Importance of iPSCs in Personalized Drug Discovery
- Persistent Advancements in Genetics Space and Subsequent Growth in Precision Medicine Augur Well for iPSCs Market
- Global Precision Medicine Market (In US$ Billion) for the Years 2018, 2021 & 2024
- Increasing Prevalence of Chronic Disorders Supports Growth of iPSCs Market
- Worldwide Cancer Incidence: Number of New Cancer Cases Diagnosed for 2012, 2018 & 2040
- Number of New Cancer Cases Reported (in Thousands) by Cancer Type: 2018
- Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
- Rising Diabetes Prevalence Presents Opportunity for iPSCs Market: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
- Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for iPSCs Market
- Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
- Growth in Number of Genomics Projects Propels Market Growth
- Genomic Initiatives in Select Countries
- New Gene-Editing Tools Spur Interest and Investments in Genetics, Driving Lucrative Growth Opportunities for iPSCs: Total VC Funding (In US$ Million) in Genetics for the Years 2014, 2015, 2016, 2017 and 2018
- Launch of Numerous iPSCs-Related Clinical Trials Set to Benefit Market Growth
- Number of Induced Pluripotent Stem Cells based Studies by Select Condition: As on Oct 31, 2020
- iPSCs-based Clinical Trial for Heart Diseases
- Induced Pluripotent Stem Cells for Stroke Treatment
- ‘Off-the-shelf’ Stem Cell Treatment for Cancer Enters Clinical Trial
- iPSCs for Hematological Disorders
- Market Benefits from Growing Funding for iPSCs-Related R&D Initiatives
- Stem Cell Research Funding in the US (in US$ Million) for the Years 2016 through 2021
- Human iPSC Banks: A Review of Emerging Opportunities and Drawbacks
- Human iPSC Banks Worldwide: An Overview
- Cell Sources and Reprogramming Methods Used by Select iPSC Banks
- Innovations, Research Studies & Advancements in iPSCs
- Key iPSC Research Breakthroughs for Regenerative Medicine
- Researchers Develop Novel Oncogene-Free and Virus-Free iPSC Production Method
- Scientists Study Concerns of Genetic Mutations in iPSCs
- iPSCs Hold Tremendous Potential in Transforming Research Efforts
- Researchers Highlight Potential Use of iPSCs for Developing Novel Cancer Vaccines
- Scientists Use Machine Learning to Improve Reliability of iPSC Self-Organization
- STEMCELL Technologies Unveils mTeSRT Plus
- Challenges and Risks Related to Pluripotent Stem Cells
- A Glance at Issues Related to Reprogramming of Adult Cells to iPSCs
- A Note on Legal, Social and Ethical Considerations with iPSCs
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/nz12r4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
